Home | Directions | Find a Job | News | Lifeline | Video | Choose a Department | Emurgent Care

Transcatheter Aortic Valve Replacement (TAVR)

Treatments


The FDA has approved the Edwards SAPIEN Transcatheter Heart Valve only for those patients with severe aortic stenosis who have been determined by a cardiac surgeon to be ineligible due to age or other medical conditions for traditional open-heart aortic valve replacement.

This minimally invasive alternative involves delivering a collapsible artificial valve into the heart using a catheter inserted through a small incision in an artery of the leg or in the chest. The artificial valve is expanded inside the diseased valve by inflating a balloon and almost immediately goes to work.

It is estimated that 300,000 U.S. patients suffer from valve deterioration each year and approximately 50,000 people undergo the conventional open-heart surgery. TVAR is proving to be a viable way to make valve replacement feasible for a broader range of patients.   

 

See the TAVR procedure in action:

Watch this 3D animation of how the TAVR procedure is performed.
See the procedure via angiogram.
 

Y